CARLYE WARD: Open Payments
NPI 1760969174 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 42 payments from 13 companies in 2025. Trend: 2023 $929 · 2024 $769 · 2025 $921
Food & beverage: $822Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $165 |
| SHIELD THERAPEUTICS INC | 5 | $122 |
| Sage Therapeutics, LLC | 5 | $88 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Smith+Nephew, Inc. | 2 | $77 |
| Organon LLC | 2 | $68 |
| Exeltis, USA Inc. | 3 | $67 |
| CooperSurgical, Inc. | 2 | $46 |
| Integra LifeSciences Corporation | 1 | $36 |
Products named: ACCRUFER, ZURZUVAE, MYFEMBREE, Pico 14, NEXPLANON, SLYND, Veozah, Paragard T 380A.
Industry payments across CA — which companies pay providers there.
